Penn launches $750M investment in science, engineering, and medicine
President Amy Gutmann has announced the launch of a $750 million investment.
Celebrating five years of innovation, entrepreneurship, and creativity
Penn Today marks the anniversary of Pennovation Works with a look at the evolution of the site, its research and commercialization achievements, and a glimpse into the future.
Novel gene therapy platform speeds search for ways to cure blindness
A newly developed single-cell RNA sequencing technique enables researchers to quickly identify an optimal vector for delivering therapeutic genetic material to treat vision disorders.
Penn establishes the Center for Precision Engineering for Health with $100 million commitment
Penn announced that it has made a $100 million commitment in its School of Engineering and Applied Science to establish the Center for Precision Engineering for Health.
Penn engineers will develop on-demand, on-site mRNA manufacturing
With an NSF grant, Penn Engineering researchers are developing a new manufacturing technique that would be able to produce mRNA sequences in a way that removes the need for cryogenic temperatures.
At-home COVID-19 results with the click of a smartphone
chers have developed a highly-sensitive rapid antigen test that can detect small loads of SARS-CoV-2
Smart dental implants
Geelsu Hwang of the School of Dental Medicine and colleagues are developing a smart dental implant that resists bacterial growth and generates its own electricity through chewing and brushing to power
Penn mRNA researchers Drew Weissman and Katalin Karikó awarded the 2021 Albany Prize
The award, one of the largest in medicine and science in the U.S., has been given for the last 20 years by Albany Medical Center to those who have altered and positively impacted the course
Engineers create faster and cheaper COVID-19 testing with pencil lead
To address cost, time and accuracy, a new electrochemical test developed by Penn researchers uses electrodes made from graphite—the same material found in pencil lead.
New cell therapy shows potential against solid tumors with KRAS mutations
A new technology for cellular immunotherapy showed promising anti-tumor activity in the lab against hard-to-treat cancers driven by the once-considered “undruggable” KRAS mutation.